Yair Einhorn
@yaireinhorn
#Science & #Innovation. Special interest in #BioTech, #GeneEditing, #EpiGeneticEditing, #GeneTherapy 🧬 #CRISPR & #Ophthalmology. #Markets & #Stocks 📈
ID:1238780417324580867
14-03-2020 10:54:12
8,2K Tweets
7,4K Followers
46 Following
1/Caribou Biosciences has presented in #AACR2024 preclinical data of CB-012 - its allogeneic, immune-cloaked, CAR-T Cell Therapy - engineered using $CRBU CRISPR chRDNA gene editing platform & aimed to treat Cancer patients with relapsed/refractory acute myeloid Leukaemia (r/r #AML ) $XBI
tRNA & the use of a suppressor tRNA, is IMO the next big breakthrough in treating rare Genetic diseases. Here’s a great interview with Michelle Werner - @Alltrna CEO & Flagship Pioneering’s CEO-Partner about tRNA & its therapeutic future. #SundayPodcast $XBI podcasts.apple.com/il/podcast/rai…
A great summary - made by my dear friend Jasbinder (Jessie) Chimni (My Opinions only), of the key highlights from CRISPR Therapeutics CEO - Samarth Kulkarni’s fireside chat at the Needham healthcare Conference. If you’re interested in CRISPR & BioTech please give him a Follow - if you are not doing so already… $XBI $CRSP